Overview
Back Bay Life Science Advisors provides strategy and investment banking guidance and execution to healthcare companies and their investors. We advise companies on healthcare technology and drug development, from planning, initial concept, and product commercialization to franchise growth, licensing, partnering, divestiture, M&A, and more.
In 2023, Back Bay partnered with DNB, a leading global financial group, to provide healthcare strategy and international capital market and investment banking guidance to global biopharma, medtech, healthtech, diagnostic, and healthcare service companies, ranging from pre-clinical startups to global multinationals.
The DNB//Back Bay Partnership for Healthcare is a committed partner throughout healthcare development, commercial and transactional journey, addressing positioning, partnering, financing, M&A strategies, and capital markets execution on US and Nordic exchanges.
Our team is comprised of more than 100 people globally who share one mission: advancing healthcare.
Meet our team and connect with us: www.bblsa.com/dnb-back-bay-healthcare-team
Learn about our partnership and read our disclosures:
United States: www.bblsa.com/dnb-back-bay-partnership